KOD - Kodiak Sciences Inc.
4.13
0.360 8.717%
Share volume: 260,568
Last Updated: 05-12-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$3.77
0.36
0.10%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-27-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 46.179 M | |
| Selling general and admin | 14.407 M | |
| Research and development | 31.772 M | |
| Total expenses | 46.179 M | |
| Operating income | -46.179 M | |
| Ebit | -46.235 M | |
| Pretax income | -44.105 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -44.105 M | |
